Nuo Therapeutics, Inc. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | 0.00% | -6.25% | +36.36% |
19/04 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
19/03 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
1st Jan change | Capi. | |
---|---|---|
+36.36% | 3.32Cr | |
+8.70% | 11TCr | |
+10.86% | 10TCr | |
-12.80% | 2.24TCr | |
-1.11% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.97% | 1.79TCr | |
+7.81% | 1.43TCr | |
+36.43% | 1.25TCr |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt